Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

NCT01896180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension
Elevated Intraocular Pressure

Interventions

DRUG: ALZ-1101
DRUG: Latanoprost

Sponsor

Alleanza Pharmaceuticals, Inc.